These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
525 related items for PubMed ID: 20437635
1. Digital morphometry of cytologic aspirate endometrial samples. Mahovlić V, Ovanin-Rakić A, Skopljanac-Macina L, Barisić A, Rajhvajn S, Juric D, Projić IS, Ilić-Forko J, Babić D, Skrablin-Kucić S, Bozikov J. Coll Antropol; 2010 Mar; 34(1):45-51. PubMed ID: 20437635 [Abstract] [Full Text] [Related]
2. Digital image analysis of silver-stained nucleolar organizer region--associated proteins in endometrial cytologic samples. Mahovlić V, Audy-Jurković S, Ovanin-Rakić A, Bilusić M, Veldić M, Babić D, Bozikov J, Danilović Z. Anal Quant Cytol Histol; 1999 Feb; 21(1):47-53. PubMed ID: 10068775 [Abstract] [Full Text] [Related]
3. Expression of the retinoblastoma-related gene Rb2/p130 is downregulated in atypical endometrial hyperplasia and adenocarcinoma. Susini T, Massi D, Paglierani M, Masciullo V, Scambia G, Giordano A, Amunni G, Massi G, Taddei GL. Hum Pathol; 2001 Apr; 32(4):360-7. PubMed ID: 11331952 [Abstract] [Full Text] [Related]
4. Papillary proliferation of the endometrium: a clinicopathologic study of 59 cases of simple and complex papillae without cytologic atypia. Ip PP, Irving JA, McCluggage WG, Clement PB, Young RH. Am J Surg Pathol; 2013 Feb; 37(2):167-77. PubMed ID: 23211295 [Abstract] [Full Text] [Related]
5. Cellular features of endometrial hyperplasia and well differentiated adenocarcinoma using the Endocyte sampler: Diagnostic criteria based on the cytoarchitecture of tissue fragments. Norimatsu Y, Shimizu K, Kobayashi TK, Moriya T, Tsukayama C, Miyake Y, Ohno E. Cancer; 2006 Apr 25; 108(2):77-85. PubMed ID: 16463402 [Abstract] [Full Text] [Related]
6. Morphometric analysis of endometrial cells in liquid-based cervical cytology samples. Gupta P, Gupta N, Dey P. Cytopathology; 2017 Apr 25; 28(2):140-148. PubMed ID: 27510614 [Abstract] [Full Text] [Related]
8. Low-grade endometrial adenocarcinoma: a diagnostic algorithm for distinguishing atypical endometrial hyperplasia and other benign (and malignant) mimics. McKenney JK, Longacre TA. Adv Anat Pathol; 2009 Jan 25; 16(1):1-22. PubMed ID: 19098463 [Abstract] [Full Text] [Related]
9. Endometrial cytology and computerized morphometric analysis of epithelial nuclei: a useful tool for reproductive diagnosis in the bitch. Groppetti D, Pecile A, Arrighi S, Di Giancamillo A, Cremonesi F. Theriogenology; 2010 Apr 15; 73(7):927-41. PubMed ID: 20116837 [Abstract] [Full Text] [Related]
10. Treatment of endometrial hyperplasias with gonadotropin-releasing hormone agonists: pathological, clinical, morphometric, and DNA-cytometric data. Agorastos T, Bontis J, Vakiani A, Vavilis D, Constantinidis T. Gynecol Oncol; 1997 Apr 15; 65(1):102-14. PubMed ID: 9103399 [Abstract] [Full Text] [Related]
11. Expression pattern of PAX2 in hyperplastic and malignant endometrium. Kahraman K, Kiremitci S, Taskin S, Kankaya D, Sertcelik A, Ortac F. Arch Gynecol Obstet; 2012 Jul 15; 286(1):173-8. PubMed ID: 22274645 [Abstract] [Full Text] [Related]
12. Significance of benign endometrial cells in Pap smears from postmenopausal women. Wu HH, Schuetz MJ, Cramer H. J Reprod Med; 2001 Sep 15; 46(9):795-8. PubMed ID: 11584479 [Abstract] [Full Text] [Related]
13. Expression of hyaluronic acid and its receptors, CD44s and CD44v6, in normal, hyperplastic, and neoplastic endometrium. Afify AM, Craig S, Paulino AF, Stern R. Ann Diagn Pathol; 2005 Dec 15; 9(6):312-8. PubMed ID: 16308159 [Abstract] [Full Text] [Related]
14. Role of Morphometry and Matrix Metalloproteinase-9 Expression in Differentiating between Atypical Endometrial Hyperplasia and Low Grade Endometrial Adenocarcinoma. Assaf MI, Abd El-Aal W, Mohamed SS, Yassen NN, Mohamed EA. Asian Pac J Cancer Prev; 2018 Aug 24; 19(8):2291-2297. PubMed ID: 30139240 [Abstract] [Full Text] [Related]
15. [Difficulties and mistakes in the diagnosis of atypical endometrial hyperplasia]. Kxmel'nitskaia NM, Neĭshtadt EL, Khalimdzhanov ZK. Arkh Patol; 2006 Aug 24; 68(6):39-42. PubMed ID: 17290894 [Abstract] [Full Text] [Related]
16. Gain of OGP, an estrogen-regulated oviduct-specific glycoprotein, is associated with the development of endometrial hyperplasia and endometrial cancer. Woo MM, Alkushi A, Verhage HG, Magliocco AM, Leung PC, Gilks CB, Auersperg N. Clin Cancer Res; 2004 Dec 01; 10(23):7958-64. PubMed ID: 15585630 [Abstract] [Full Text] [Related]
17. [A comparative morphometric and DNA content study of endometrial hyperplasia and adenocarcinoma]. Zhou XR, Du XG. Zhonghua Fu Chan Ke Za Zhi; 1992 Sep 01; 27(5):278-80, 316. PubMed ID: 1298588 [Abstract] [Full Text] [Related]
18. Morphometry of tumor cells in different grades and types of breast cancer. Prvulović I, Kardum-Skelin I, Sustercić D, Jakić-Razumović J, Manojlović S. Coll Antropol; 2010 Mar 01; 34(1):99-103. PubMed ID: 20437638 [Abstract] [Full Text] [Related]
19. Digital imaging analysis of normal, hyperplastic and malignant endometrial cells in endometrial brushing samples. Fu YS, Ferenczy A, Huang I, Gelfand MM. Anal Quant Cytol Histol; 1988 Apr 01; 10(2):139-49. PubMed ID: 3390290 [Abstract] [Full Text] [Related]
20. Increased natural killer cells and decreased regulatory T cells are seen in complex atypical endometrial hyperplasia and well-differentiated carcinoma treated with progestins. Witkiewicz AK, McConnell T, Potoczek M, Emmons RV, Kurman RJ. Hum Pathol; 2010 Jan 01; 41(1):26-32. PubMed ID: 19733383 [Abstract] [Full Text] [Related] Page: [Next] [New Search]